Table 2 Patients’ baseline drug resistance pattern
Variables | Frequency (%) |
|---|---|
Number and pattern drug resistance | |
One | 83 (39.0) |
R | 83 (39.0) |
Two | 32 (15.0) |
RH | 31 |
R + Eto | 1 |
Three | 37 (17.4) |
RH + FQ | 14 |
RHZ | 12 |
RHS | 5 |
RHE | 4 |
RH + SLI | 2 |
Four | 21 (9.9) |
RHEZ | 9 |
RHZ + FQ | 5 |
RHZS | 3 |
RHES | 2 |
REZS | 1 |
RHZ + SLI | 1 |
Five | 25 (11.7) |
RHEZS | 14 |
RHEZ + FQ | 8 |
RHES + FQ | 2 |
RHZS + Eto | 1 |
Six | 12 (5.6) |
RHEZS + FQ | 12 |
Seven | 3 (1.4) |
RHEZS + FQ + Eto | 3 |
Resistance to R | 213 (100) |
Resistance to H | 129 (60.6) |
Resistance to E | 54 (25.4) |
Resistance to Z | 67 (31.5) |
Resistance to S | 48 (21.9) |
Resistance to all five FLDs | 29 (13.6) |
Resistance to any SLDs | 50 (23.0) |
Resistance to FQs | 45 (21.1) |
Resistance to any SLI | 3 (1.4) |
Resistance to Eto | 5 (2.3) |